The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined intraperitoneal and systemic chemotherapy as adjuvant or perioperative chemotherapy for patients with type 4 scirrhous gastric cancer: PHOENIX-GC2 trial.
 
Hironori Ishigami
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)
 
Takeshi Omori
Honoraria - DAIICHI SANKYO COMPANY, LIMITED
Research Funding - DAIICHI SANKYO COMPANY, LIMITED (Inst)
 
Yasushi Tsuji
Honoraria - Chugai Pharma; Daiichi Sankyo/UCB Japan; Lilly Japan; Medicon; Merck Serono; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hisashi Shinohara
Honoraria - Bristol-Myers Squibb; Johnson & Johnson; Lilly Japan; Medtronic; MSD; Olympus; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
 
Hiroshi Yabusaki
No Relationships to Disclose
 
Daisuke Kobayashi
No Relationships to Disclose
 
Daisuke Takahari
Honoraria - Bristol-Myers Squibb Japan; Daiichi Sankyo/UCB Japan; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Hiroaki Hata
No Relationships to Disclose
 
Tetsuya Kusumoto
No Relationships to Disclose
 
Mitsuro Kanda
No Relationships to Disclose
 
Koji Oba
Honoraria - Eisai; Janssen; Ono Pharmaceutical
Speakers' Bureau - Chugai Pharma
 
Joji Kitayama
Honoraria - Chugai Pharma; Lilly Japan; Nihonkayaku; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Nihon Pharma; Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Yasuyuki Seto
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst)